Physician profile
Marc E Serve
NPI 1013300425
$449.69
in general payments reported to CMS, 2019-2025
9 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $13.31 · 2023: $16.11 · 2024: $52.70 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $137.49 | 2019 | |
| Novo Nordisk INC | $123.64 | 2025 | Wegovy |
| Exact Sciences Corporation | $64.05 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $41.85 | 2024-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $21.01 | 2019 | |
| Merck Sharp & Dohme LLC | $16.25 | 2025 | Gardasil 9, Capvaxive, M-M-R II |
| Abbvie INC. | $16.11 | 2023 | Ubrelvy |
| Ibsa Pharma INC. | $15.98 | 2024 | Tirosint, Licart, Flector |
| Antares Pharma, INC. | $13.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Serve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.